Williams et al Flashcards Preview

Y2: Psychology: Clinical: Depression > Williams et al > Flashcards

Flashcards in Williams et al Deck (13)
Loading flashcards...
1
Q

What was the sample of Williams et al. study?

A

69 patients.

  • 31 patients on the waiting list control group.
  • 38 in the treatment group.
2
Q

How was the sample recruited?

A
3
Q

Describe the 5 primary baseline measures used + why…

A

Beck’s Depression Inventory (BDI) and Patient Health Questionnaire Depression Scale (PHQ-9) to measure depression.

Kessler’s psychological distress scale was used to index distress.

The Ambiguous Scenarios test was used to measure interpretation bias for depression for depression and an electronic version of the Scrambled Sentences test.

4
Q

What were the secondary measures based on?

A

Based on:

  • The WHO Disability Assessment Schedule II
  • The State Trait Anxiety Inventory
  • The repitive thinking Questionnaire.
5
Q

Give other measures + their use

A

Short questionnaires were designed to provide the evaluation of the treatment.

6
Q

What did the treatment group undergo?

A

The treatment group underwent a 20-minute daily treatment of cognitive bias modifications using imagery for the first week followed by the iCBT programme which lasted a further 10 weeks.

7
Q

Was face to face contact made between patient and client?

A

no.

8
Q

What did the iCBT programme consist of?

A
9
Q

Were the baseline measures repeatd at the end?

A
10
Q

What did pre-treatment tests show?

A

Pre-treatment tests showed no sig differences between

11
Q

Describe the

A

After the first week of CBM I training, there was a reduction in depression scores and the distress scores in the treatment group with clinically significant changes evident in 7 of the treatment group compared to only 2 in the WLC (waiting list control) group.

12
Q

Describe the results at week II

A

Analysis at week II showed sig reductions in all primary measures for both treatment group and the WLC but the reductios were much longer in the treatment group where 65% of patients showed clinically sig changes

13
Q
A